NCT03048240 2026-02-05
INDYGO
University Hospital, Lille
Phase NA Completed
Clinical Trials
63 trialsNCT05735171 2025-12-24
SupraGlio-AI
Hospital del Rio Hortega
Phase NA Completed
NCT04566185 2025-12-18
EVA DOPA
Centre Hospitalier Universitaire de Nīmes
Phase NA Completed
NCT03975959 2025-09-23
PROMESSE
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Completed
NCT05383872 2025-07-28
Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain Tumors
InSightec
Phase NA Completed
NCT04734444 2025-06-17
SonoClear Acoustic Coupling Fluid (ACF) Mimicking Brain Tissue
SonoClear AS
Phase NA Completed
NCT04610229 2025-06-12
GLIORAD
Azienda USL Reggio Emilia - IRCCS
Phase NA Completed
NCT05759195 2025-03-13
RegoRec
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase NA Completed
NCT05772767 2025-03-13
RF2019-1236878
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase NA Completed
NCT05131815 2025-02-26
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
Cedars-Sinai Medical Center
Phase NA Completed
NCT05140902 2025-02-14
Accurate DCE-MRI Measurement of Glioblastoma Using Point-of-care Portable Perfusion Phantom
University of Alabama at Birmingham
Phase NA Completed
NCT05296122 2025-01-15
Safety and Feasibility of MR-guided Laser Thermal Ablation of Brain Lesions
Clinical Laserthermia Systems AB
Phase NA Completed
NCT05015543 2024-12-12
MMH
University Hospital Muenster
Phase NA Completed
NCT04726397 2024-11-29
UNITED
Sunnybrook Health Sciences Centre
Phase NA Completed
NCT03922984 2024-10-22
Non-Contrast Perfusion Using Arterial Spin Labeled MR Imaging for Assessment of Therapy Response in Glioblastoma
University of Texas Southwestern Medical Center
Phase NA Completed
NCT03926507 2024-10-09
F18 Fluciclovine PET/CT in Assessing Tumor Volume and Radiation Therapy Response in Patients With Glioblastoma Undergoing Surgery
M.D. Anderson Cancer Center
Phase NA Completed
NCT01923922 2024-08-21
CT Perfusion in the Prognostication of Cerebral High Grade Glioma
Nova Scotia Health Authority
Phase NA Completed
NCT06038604 2024-07-31
Glioblastoma Psychosocial Support Program
Duke University
Phase NA Completed
NCT02441322 2024-07-19
Evaluating Therapeutic Response to Novo-TTF
Abramson Cancer Center at Penn Medicine
Phase NA Completed
NCT04604158 2024-05-21
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
Cedars-Sinai Medical Center
Phase NA Completed
NCT03551249 2024-03-05
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption
InSightec
Phase NA Completed
NCT03616860 2024-01-23
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) Disruption for Treatment of Glioma
InSightec
Phase NA Completed
NCT03557372 2023-10-26
Mathematical Model-Adapted Radiation In Glioblastoma
Dana-Farber Cancer Institute
Phase NA Completed
NCT04446416 2023-09-06
Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients
NaviFUS Corporation
Phase NA Completed
NCT03538587 2023-08-01
Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers
National Institutes of Health Clinical Center (CC)
Phase NA Completed
NCT05896449 2023-06-09
Predictive Values of Preoperative [68Ga]Ga-PSMA-11 PET/CT in Patients With Suspected Brain Tumours of Glial Origin
Medical University of Warsaw
Phase NA Completed
NCT04630379 2023-03-20
Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers
Mayo Clinic
Phase NA Completed
NCT02296580 2023-02-02
A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)
Nativis, Inc.
Phase NA Completed
NCT04114786 2022-10-21
3D Printed Mask for GBM and Brain Mets
University Health Network, Toronto
Phase NA Completed
NCT04596930 2022-08-09
EMITT
Radboud University Medical Center
Phase NA Completed
NCT03390569 2022-04-14
Exercise in Patients With Glioblastoma
University Health Network, Toronto
Phase NA Completed
NCT02359097 2022-03-17
Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma
OHSU Knight Cancer Institute
Phase NA Completed
NCT04516733 2022-03-14
GLIOSUPPORT
Institut du Cancer de Montpellier - Val d'Aurelle
Phase NA Completed
NCT02379572 2021-10-22
Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
University Hospital Tuebingen
Phase NA Completed
NCT02076152 2021-07-30
FMISO PET Study of Glioblastoma
Massachusetts General Hospital
Phase NA Completed
NCT01754350 2021-06-02
ERGO2
Johann Wolfgang Goethe University Hospital
Phase NA Completed
NCT00400322 2021-03-01
Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection
Karolinska Institutet
Phase NA Completed
NCT02631655 2021-02-16
POSEIDON
Centre Antoine Lacassagne
Phase NA Completed
NCT01987830 2020-09-04
Bevacizumab w / Temozolomide PET & Vascular MRI For GBM
Massachusetts General Hospital
Phase NA Completed
NCT01813877 2020-07-27
Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
Jonsson Comprehensive Cancer Center
Phase NA Completed
NCT02286167 2020-05-12
GLAD
Wake Forest University Health Sciences
Phase NA Completed
NCT02431572 2020-04-28
A Pilot Study to Evaluate PBR PET in Brain Tumor Patients Treated With Chemoradiation or Immunotherapy
Massachusetts General Hospital
Phase NA Completed
NCT01540513 2019-12-02
PET/CT Evaluation of Primary and Metastatic Brain Tumors With a Novel Radioiodinated Phospholipid Ether Analogue I-NM404
University of Wisconsin, Madison
Phase NA Completed
NCT02374255 2019-10-01
Improving Goals of Care Discussion in Advanced Cancer Patients
Icahn School of Medicine at Mount Sinai
Phase NA Completed
NCT03626896 2019-06-21
Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients
NaviFUS Corporation
Phase NA Completed
NCT01478854 2019-06-13
Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase NA Completed
NCT02410577 2019-03-19
89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT01810744 2019-03-15
BEVACAPI
Centre Georges Francois Leclerc
Phase NA Completed
NCT02575027 2019-02-28
Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma Multiforme
Jonsson Comprehensive Cancer Center
Phase NA Completed
NCT00276770 2019-02-27
Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas
University of Washington
Phase NA Completed